Dapagliflozin: more than just another oral glucose-lowering agent?

Dapagliflozin: more than just another oral glucose-lowering agent?

Item
http://www.wikidata.org/entity/Q37812136
Sodium-Glucose Cotransporter 2 Inhibitors: Possible Anti-Atherosclerotic Effects Beyond Glucose LoweringManagement of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines.The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study.Dapagliflozin: a review on efficacy, clinical effectiveness and safety.The kidney as a new target for antidiabetic drugs: SGLT2 inhibitors.Industrial natural product chemistry for drug discovery and development.Combination therapy for type 2 diabetes: dapagliflozin plus metformin.SGLT2 inhibitors in the pipeline for the treatment of diabetes mellitus in Japan.Gout and diabetes: a common combination.Tofogliflozin: the road goes ever on.Safety, tolerability, pharmacokinetics and pharmacodynamics following 4 weeks' treatment with empagliflozin once daily in patients with type 2 diabetes.Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis.Dapagliflozin therapy in type-2 diabetes: current knowledge and future perspectives.Bioequivalence of fixed-dose combinations of dapagliflozin and metformin with single-component tablets in healthy subjects and the effect of food on bioavailability.Luseogliflozin and other sodium-glucose cotransporter 2 inhibitors: no enemy but time?
P2860

Dapagliflozin: more than just another oral glucose-lowering agent?

Item
http://www.wikidata.org/entity/Q37812136
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dapagliflozin: more than just another oral glucose-lowering agent?
@en
Dapagliflozin: more than just another oral glucose-lowering agent?
@nl
type
label
Dapagliflozin: more than just another oral glucose-lowering agent?
@en
Dapagliflozin: more than just another oral glucose-lowering agent?
@nl
prefLabel
Dapagliflozin: more than just another oral glucose-lowering agent?
@en
Dapagliflozin: more than just another oral glucose-lowering agent?
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Dapagliflozin: more than just another oral glucose-lowering agent?
@en
P2093
P304
P31
P356
10.1517/13543784.2011.539558
P407
P433
P478
P50
P577
P698
P921